Monday, November 19, 2012

Progressing towards using telehealth

NST

SINGAPORE: REMOTE CARE: A growing ageing population, shortage of doctors and nurses are leading to change

.
Telehealth will not take away the personal interaction with hospital staff.
HOSPITALS in Malaysia should consider investing more in telehealth to improve healthcare delivery and efficiency in the country.
Telehealth or telemedicine involves the use of proprietary software and electronic devices with audio and visual capabilities to assist in the provision of medical care to patients.
"With only 30 intensivists (intensive care unit specialists) in Malaysia, remote areas with less developed healthcare facilities, for example in East Malaysia, can capitalise on the expertise available in the peninsula by centrally managing patients across the nation.
"This would help improve the overall healthcare quality across the whole country," said Philips Healthcare Asia Pacific senior vice-president and commercial leader Wayne Spittle in an interview during a healthcare session at the Philips Asia Media Summit here recently.
Spittle said telehealth solutions would not take away the personal interaction between patients and hospital staff as it still provides the human touch through its audio and visual capabilities.
"There is immediate medical attention throughout the day, unlike the standard mode of operation today, where patients need to wait to receive medical attention because of travel time between wards and across the entire hospital."
Several countries have begun capitalising on telehealth.
At a general hospital in Orange, New South Wales, Australia, beds have been linked to a clinical information portfolio computer system to give staff immediate access to patients' conditions from a central location.
Singapore hospitals have invested in ICU IT solutions to enable critical care medical staff to actively monitor patients in ICUs from remote locations.
The Hanh Phuc International Women and Children hospital in Vietnam has a central maternal-fetal monitoring station as well as wireless foetal monitoring solutions which provide clinicians with vital information to track patients throughout the labour and delivery period.
Surgeons at the Methodist Hospital in Houston, the United States, use a robotic system controlled from a remote location to unblock the arteries of patients with blocked peripheral arteries. Using video and integrated medical devices, medical experts are now providing services to communities in the most remote areas.
Industry analyst Datamonitor estimated that this year, the global spending on overall telehealth market (including home telehealth) will exceed US$6 billion (RM18.4 billion).
Spittle said with a growing ageing populations, the rise of chronic non-communicable diseases and the shortage of doctors and nurses, hospitals would lead the shift to telehealth solutions.

Saturday, November 17, 2012

Public-private partnership to improve facilities at Sarawak General Hospital

The Star Online

KUCHING: The Government has approved a project under public-private partnership (PPP) programme to improve facilities at Sarawak General Hospital (SGH).
Health Minister Datuk Seri Liow Tiong Lai said the programme would involve building, among other things, multi-storey car parks, daycare centre, pathology laboratory, medical apartment, and a blood bank at a total cost exceeding RM300mil.
“The most important is the multi-storey car parks due to the congestion in the hospital compound. The project tender will be called soon.
“As for the cost breakdown for each project, it has not been ascertained yet,” he told reporters after a working visit to SGH yesterday.
He said the programme was a priority under Budget 2013 which had allocated RM193mil for 35 approved healthcare development projects in the state next year.
“A lot of these projects including clinics under the Budget are already going on as they are under the rolling plan,” he said.
Under the Budget, the Government had approved an allocation of RM1.9bil for 257 projects nationwide.
Besides these projects, Liow also revealed that a RM35mil clinical research centre and a RM3mil acute psychiatric ward at SGH would be ready by next year.
The RM32mil Petra Jaya Health Clinic and a new RM5.5mil state-of-the-art mortuary with a good forensic service will also be ready by the end of the year.
Liow said the services at the SGH would be further enhanced with additional beds, with two vacant floors at the SGH Heart Institute in Kota Samarahan to be used for the purpose.
“The hospital has seen an improved performance as the number of beds has increased to 934 now compared to about 700 in 2009,” he said.
He said the Government had never neglected the healthcare services in the state.
“We have a lot of clinics here with eight more 1Malaysia Clinics to be built in the state next year.
“We also have the mobile clinics and flying doctor services.
“There will be more doctors to be sent here as there are 3,500 newly trained doctors every year,” he said.
He said doctors posted to the state were encouraged to serve in rural areas as it was a national call that they should take up.
“We give them incentives and promotional opportunities after two years of service and we have even shortened the period to six months for the specialists.
“In fact, a lot of these doctors have stayed back after that and some are even willing to serve in rural areas,” he said.
On a question about hospital security, he said money had been allocated to it.

Tuesday, November 13, 2012

Health Ministry looks to lure doctors to 1 Malaysia clinics @ Sun Nov 11 2012

MI

ERANTUT, Nov 11 — The Health Ministry is implementing two pioneer projects to encourage doctors from the private sector to serve at the 1 Malaysia Clinics.
Minister Datuk Seri Liow Tiong Lai said the two pioneer projects were carried out at the 1 Malaysia Clinics in Malacca and Kerinchi in Kuala Lumpur to test their effectiveness.
“We will co-operate with doctors from the private sector at the two clinics and see if we get good response from them,” he said after opening the Jerantut 1 Malaysia Clinic, here, today.
Liow (picture) said every private medical practitioner would be paid RM80 an hour for their services at the clinics.
“We encourage them to serve at the 1 Malaysia Clinics, and it is up to them if they want to serve for one or two hours,” he said.
He said there were currently 22 1 Malaysia Clinics where the ministry placed doctors at clinics receiving more than 100 patients a day to avoid congestion at the hospitals and health clinics.
According to Liow, there were about 150 1 Malaysia Clinics nationwide and the ministry targeted to create 20 more by the year-end.
“Next year, as announced by the prime minister, we will add another 70 1 Malaysia Clinics,” said Liow.
Meanwhile, he said the ministry allocated RM10 million to build quarters for health clinic personnel in Kuala Tahan, Damak and Kampung Bantal, all in Jerantut.
He said the construction of the quarters would commence soon and was expected to be completed next year. — Bernama

Thursday, November 08, 2012

Liow: 800 doctors pursuing specialist courses

New Straits Times

KUALA LUMPUR: The Health Ministry is sponsoring some 800 doctors to pursue specialist and subspecialist training to address the shortage of such professionals in the country.

Its minister, Datuk Seri Liow Tiong Lai, said the figure was an increase from only 400 in 2010, with over 90 subspeciality programmes.
"The ministry has been sending doctors to local and foreign institutions to further their medical education up to the Masters and PhD level upon which they can specialise and sub-specialise overseas," he told reporters after launching the First Stem Cell Congress here yesterday.
"This is to tackle the shortage of specialist doctors in government hospitals."
The popular areas of study included nephrology, cardiology, gastroenterology, rheumatology, urology, breast and endocrine surgery, intensive care, spine orthopaedics as well as neonatology. It was noted that there were currently 5,000 specialists nationwide of which 3,000 were serving in the public sector.
Liow said a specialist wishing to sub-specialise would be required to undergo supervised training under a consultant for two to three years locally, followed by additional exposure in overseas training centres for about a year.
"The ministry has been sending doctors for specialist training to, among others, the United Kingdom, Australia, and Europe."
He also highlighted a new development in postgraduate medical speciality training, an agreement with the Royal College of Physicians Ireland accepting about 80 students a year, with the first batch to start next year.
He said as of this month, there were 333 trainees in the training programme and the number of new intakes varied between 100 to 130.
"Local universities have also been training a lot of doctors under the masters programme and they are given the opportunity to go overseas for subspeciality training. We also urge private hospitals to train specialists on their own to assist the government in tackling the shortage of specialist doctors in the country."
The country's 30 medical schools were producing an estimated 4,000 to 5,000 doctors annually.
Liow said there were 35,000 doctors in the country and the government hoped the ratio of one doctor to 400 people could be achieved by 2020.
On the proposed 1Care Health Plan, Liow said the public should not be worried about the plan as nothing was finalised.

Tuesday, November 06, 2012

Health ministry orders products to be taken off shelves

AsiaOne

GEORGE TOWN, MALAYSIA - The Health Ministry has ordered all Ayamas products in the same batch that was found to contain a banned antibiotic be taken off the market.
Minister Datuk Seri Liow Tiong Lai said yesterday his ministry had ordered the withdrawal of the products pending tests.
"I am now waiting for the results of the tests done on the samples. We view this seriously and that is why we decide to withdraw the batch from the market."
However, he said Ayamas products that were not from the same batch could continue to be sold. Liow was commenting on the Sarawak Veterinary Authority's immediate ban on all Ayamas products following a random test where traces of Chloramphenicol were found.
Chloramphenicol is used to treat animals but is not safe for human consumption and, therefore, cannot be used in food processing.
On Saturday, Sarawak Assistant Agriculture Minister Mong Dagang said he believed the problem could lie in the source of the chickens and not during the processing part.
Chloramphenicol is banned in most Western countries although it is available in Southeast Asia. The drug is known to cause blood disorders such as aplastic and hypoplastic anaemia.
Any interactions between Chloramphenicol and diabetic medicines, or even vitamin B12 supplements, may cause allergic reactions, including stomach upset, diarrhoea, headache, nausea and vomiting.

Boost for healthcare and well-being

The Star Online


THE Government has allocated RM19.3bil for healthcare management and development services next year. This is a 15% increase compared with last year.
Datuk Seri Najib Tun Razak said the 1Malaysia Clinics would begin to offer cholesterol and glucose testing services as well as urine tests for those who needed them.
As for the reduced sugar subsidy, he said this was done as 2.6 million Malaysians were diabetic.
“The Government urges retailers not to burden fellow Malaysians by increasing prices. Instead, reduce the content of sugar,” he said.
Najib added that the subsidy reduction was supported by consumers groups and health practitioners.
The Prime Minister said that the Government would still be subsidising sugar at 34 sen per kilo, totalling RM278mil.
Interests groups welcomed the reduction of sugar subsidy but some of them were not happy that the 1Malaysia Clinics are affecting private practice.
For instance, Malaysian Medical Association president Dr S.R. Manalan said they were disappointed that the Government did not include the request of private doctors to incorporate their services in the 1Malaysia Clinic scheme.
“We have mentioned to the Government that the programme had affected the livelihood of many private doctors.
“The Government said the doctors could sign up for slots in general hospitals but these slots were always full, filled up by their own doctors,” he said.
Dr Manalan also said that breast cancer had become more common among those aged 40 and below, thus allocations should be made for them for other forms of screening such as ultrasound.
On the RM200mil allocation for Socso to enable 1.4 million workers to go for free check-ups, he said it was a good effort but there must be follow-up efforts to their cases.
Fomca deputy president Muhammad Sha’ani Abdullah said the Government should engage private practitioners for 1Malaysia Clinics instead of creating more clinics by renting new premises and employing additional medical assistants and staff.
He noted that there was no mention of the healthcare financing scheme, which was needed in view of Malaysia becoming an ageing population.
“This must come as soon as possible because healthcare cost has escalated and affecting consumers,” he said.

    Monday, November 05, 2012

    Govt to get tough on smokers

    The Star Online

    SEREMBAN: With an estimated 100,000 Malaysians dying every year from smoke-related illnesses, the Government may resort to having each cigarette stick printed with the words Smoking is hazardous to health.
    In another drastic move to discourage people particularly the young from picking up the habit, cigarette manufacturers may also be barred from making claims regarding tobacco grade, quality and flavour of their product.
    These and other new provisions are likely to be included in the Control of Tobacco Product Regulations 2004 when the Government intensifies its enforcement to make public places in the country absolutely smoke-free.
    A government source told The Star that the Health Ministry would, in the next two weeks, seek public feedback online on its tough plan to discourage Malaysians from ruining their health through smoking.
    The source said the proposed amendments are in line with the Global Adult Tobacco Survey (GATS) Malaysia 2011 carried out recently, in which 83.5% of the respondents want 100% smoke-free public places.
    “Under the ministry's proposal, the words Merokok Membahayakan Kesihatan should be clearly printed on every cigarette stick to remind existing and potential smokers on the dangers of lighting up,” the source said.
    “With some 4,000 chemicals in cigarettes and cigarette smoke which, among others, have carcinogenic effects, the ministry also wants the tar and nicotine levels in cigarettes to be further cut,” he said.
    It is learnt the ministry is proposing for the nicotine levels to be cut from 1.5mg to 1.25mg per stick and from 20mg to 15mg for tar content.
    It wants this to be further reduced to 1mg (nicotine) and 10mg (tar) in due course.
    The source said tobacco companies have, however, requested that the nicotine levels in cigarettes be reduced to only 1.3mg and tar levels to 15mg from 2014 and to 1mg and 10mg respectively by 2018.
    “Also on the cards are provisions to compel manufacturers to increase the size of pictorial health warnings on their packs on the effects of smoking, from at least 40% currently to 50%,” the source said.
    “The ministry is already looking at the Australian model, where tobacco companies are allowed only to sell their products in plain packaging; thus, being unable to use the strength of their brandname to market their product,” he said.
    Under the plain packaging method, tobacco companies are not allowed to display their brand colours or logos on the packs.
    The source said tobacco companies and importers will also be required to officially write in to the ministry each time they revise the retail price of their product.
    “Another amendment states that smokers will also no longer be allowed to light up along the five-foot way or in any covered area which is part of a premises.
    “In other words, if there is a perimeter wall outside a building, smokers will not be allowed to light up within the area,” he said.

    100 doctors overseas want to come home to serve

    The Star Online


    KULIM: About 100 Malaysian doctors and medical specialists working overseas have expressed their interest to return to serve the country, said Health Minister Datuk Seri Liow Tiong Lai.
    He said the number was obtained during road shows conducted byTalent Corp, a Government-owned agency that has been mandated to recruit and nurture talent locally and abroad.
    The doctors and medical specialists were currently residing in Taiwan, Australia and United Kingdom, he said.
    Liow said he was told that Talent Corp received many enquiries during visits to Taiwan and Australia recently.
    “More importantly, many of them have expressed keen interest to come back. Some of them are well-known in their fields. We are happy and touched,” he said after a visit to the Kulim Hospital yesterday.

    Monday, October 29, 2012

    Liow says law on stem cells not yet needed

    MI

    KUALA LUMPUR, Oct 29 — The Health Ministry did not have plans to introduce a law on stem cells at the moment, said Datuk Seri Liow Tiong Lai.
    He said the ministry’s four guidelines on stem cell research sufficiently served as standards to which practitioners and scientists involved in stem cell research and therapy should adhere and to ensure patients were out of harm’s way.
    The guidelines would provide a framework for researchers, clinicians and companies involved in research, clinical trials and manufacture of stem cells, he noted.
    “There is no Stem Cell Act in this country. But the guidelines alone are sufficient to provide the grounds and ethical environment to carry out their work,” Liow (picture) told reporters after launching the 1st National Stem Cell Congress here today.
    The four guidelines are National Standards For Haemopoietic Stem Cell Therapy, National Standards For Cord Blood Banking and Transplantation, National Standards For Stem Cell Transplantation and Guidelines On Stem Cell Research and Therapy.
    Liow said: “Before we came up with the guidelines, we formed a committee to discuss the details of the research. The committee also included Jakim and religious officials for their views.”
    He said the use of cell-based therapies should be done strictly under clinical trials.
    Prior to the clinical trials, there must be sufficient evidence to show safety, quality and efficacy.
    Meanwhile, Liow said stem cell therapy in Malaysia was developing well in government, as well as university hospitals, noting that the number of patients receiving bone marrow and stem cell transplantation for leukaemia and solid tumours was on the rise.
    He said a total of 213 haemopoietic stem cell transplants were performed and registered in the country, the majority of which centred on malignant disorders, namely leukaemia and lymphoma.
    Currently, the minister disclosed, there were 11 haemopoietic transplant centres performing haemopoietic stem cell transplants in the country, including Ampang Puteri Specialist Hospital, Haematology Department (Ampang Hospital), Haemopoietic Stem Cell Transplant Unit (Universiti Sains Malaysia Hospital) and Paediatric BMT Unit, Institute of Paediatrics Kuala Lumpur Hospital.
    In another development, Liow announced that the Royal College of Physicians of Ireland (RCPI) has agreed to accept 80 students annually, to undergo the Medical Subspeciality Training Programme.
    He said RCPI would provide an average of two to five years training places for most of the sub-specialities being offered, commencing from the 2013 intake.
    The areas offered include cardiology, palliative medicine, endocrinology, gastroenterology, neurology, infectious diseases and geriatric medicine. — Bernama

    Pengasih wants abuse of kratom leaves penalised under Dangerous Drugs Act @ Sun Oct 28 2012

    MI


    KUALA LUMPUR,  Oct 28 — Drug rehabilitation organisation Pengasih Malaysia today urged the attorney-general to penalise the abuse of kratom (ketum) leaves under the Dangerous Drugs Act instead of the Poisons Act, and also to regard glue-sniffing under the former law as well.
    Pengasih president Datuk Mohd Yunus Pathi said this was necessary to check the abuse of kratom leaves, which were addictive, especially if mixed with certain items.
    He said a study by Pengasih found that some adults in their 40s consumed a kratom extract mixed with coffee or other drinks to boost their energy.
    “Taking a kratom drink on a regular basis will have an adverse effect on the health of the consumer,” he told reporters at Rumah Pengasih, here.
    Mohd Yunus also regarded the sniffing of glue as a serious problem.
    “There is no specific law on sniffing glue, although the practice can cause brain damage and lead to crime and social ills,” he said.
    He proposed that the aftercare programme for former drug addicts be reviewed as certain aspects were seen as obstacles for them to lead a normal life. —  Bernama

    Pengasih wants abuse of kratom leaves penalised under Dangerous Drugs Act @ Sun Oct 28 2012

    MI


    KUALA LUMPUR,  Oct 28 — Drug rehabilitation organisation Pengasih Malaysia today urged the attorney-general to penalise the abuse of kratom (ketum) leaves under the Dangerous Drugs Act instead of the Poisons Act, and also to regard glue-sniffing under the former law as well.
    Pengasih president Datuk Mohd Yunus Pathi said this was necessary to check the abuse of kratom leaves, which were addictive, especially if mixed with certain items.
    He said a study by Pengasih found that some adults in their 40s consumed a kratom extract mixed with coffee or other drinks to boost their energy.
    “Taking a kratom drink on a regular basis will have an adverse effect on the health of the consumer,” he told reporters at Rumah Pengasih, here.
    Mohd Yunus also regarded the sniffing of glue as a serious problem.
    “There is no specific law on sniffing glue, although the practice can cause brain damage and lead to crime and social ills,” he said.
    He proposed that the aftercare programme for former drug addicts be reviewed as certain aspects were seen as obstacles for them to lead a normal life. —  Bernama

    Saturday, October 27, 2012

    Liow: Incentives for private hospitals that hire newly graduated nurses

    The Star Online


    CAMERON HIGHLANDS: The Government is planning to give incentives to private hospitals that employ fresh graduates from nursing colleges, said Health Minister Datuk Seri Liow Tiong Lai.
    He said the move is aimed at encouraging private hospital to absorb nurses who had passed the Malaysia Nursing Board examination.
    "By offering incentives to private hospitals, we hope they would be more willing to employ new nurses," he told reporters after meeting Tringkap residents here on Saturday.
    Private hospitals also play an important role to train new nurses, he added.
    "This would be a solution to reduce private hospitals from pinching experienced nurses from the Health Ministry," he said.
    He said he would soon be announcing more details about the scheme the Ministry has come up with.
    Touching on the quality of nurses in Malaysia, Liow said nurses had lived up to the expectation of the healthcare sector.
    "It is unfair to say Malaysian nurses are lack of quality.
    "If they have passed the examination, that means they have acquired sufficient healthcare knowledge," he said.
    He was commenting on a special news reporting by a television channel that claimed nurses in the country were not up to standard.
    He said nurses, especially fresh graduates from nursing colleges, require clinical exposure to enhance their clinical expertise.
    The Government is also studying at recruiting nurses to undergo 1Malaysia Training Scheme to improve their skills, he added.

    Thursday, October 25, 2012

    Cosmeceutical straddles the grey area

    The Star

    THE term “cosmeceutical” is not recognised by the Ministry of Health Malaysia (MOH), according to Datuk Eisah A. Rahman (pic), senior director of Pharmaceutical Services of the MOH.
    It is not regulated as a product under the Sale of Drugs Act 1952, and the Control of Drugs and Cosmetics Regulations 1984.
    “A product can be a drug or a cosmetic, but it cannot be a combination of both. A cosmetic product cannot have either medicinal or drug-like benefits,” Datuk Eisah says in a recent e-mail interview.
    According to the above act and regulations, there is a clear definition whereby a “drug” includes any substance, product or article intended to be used or capable, or purported or claimed to be capable, of being used on humans or any animal, whether internally or externally, for medicinal purposes.
    On the other hand, “cosmetic” means any substance or preparation intended to be placed in contact with the various external parts of the human body (including epidermis, hair system, nails, lips and external genital organs), or with the teeth and the mucous membranes of the oral cavity, with a view exclusively or mainly to clean them, perfume them, change their appearance or correct body odours, protect them or keep them in good condition.
    “Skincare products with functional claims such as anti-ageing can be considered as cosmetics in Malaysia as it is not categorised to have medicinal or drug-like benefit,” she clarifies.
    She explains that the scope of anti-ageing claims, which is acceptable as cosmetics in Malaysia, generally covers products for improvement of the skin appearance such as reducing the appearance of wrinkle, skin hydration or even skin tone.
    “Such products cannot be claimed to treat or prevent disease in humans; permanently restore, correct or modify physiological function by exerting a pharmacological, immunological or metabolic action,” she stressed.
    Under the Control of Drugs and Cosmetics Regulations 1984, the beauty company responsible for placing a cosmetic product in the local market must notify MOH prior to manufacture, import, supply or sale of the products and must ensure the safety, quality and claimed benefit of the cosmetic product placed in the local market. Malaysia implemented the notification procedure for cosmetic products since Jan 1, 2008.
    All notified cosmetics are subjected to the MOH Post Market Surveillance programme to ensure that only safe products are marketed in Malaysia, and failure to comply with the relevant authorities will result in punitive action such as notification cancellation and product recall.
    “Even though the notification procedure is less stringent compared to registration of drugs, nevertheless, for a product to be classified as cosmetics it must comply with the definition of cosmetics, and it is prohibited to make any medicinal claims,” Eisah points out.
    When beauty companies call their products “cosmeceuticals”, it may be misleading to the consumer if the consumer interprets the product to be similar to a pharmaceutical product.
    In accordance to the Cosmetic Advertising Code as specified under the Guidelines for Control of Cosmetic Products in Malaysia, the cosmetics industry is required to ensure that the marketing and advertising of cosmetics to the public is conducted in a manner that promotes the quality and safe use of cosmetics.
    “That manner must be socially responsible, and not deceive the consumer. Advertisements should not be framed so as to abuse the trust of the consumer, or exploit his or her lack of experience or knowledge,” Eisah explains.
    Before purchasing a cosmetic product, she advises consumers to read the product labels thoroughly and make an informed decision.
    “They should not be easily influenced by advertisements that promise spectacular results in a short time.”
    Cosmetic products are only approved for external application, and should never be injected into the body or under the skin by any method.
    “Consumers are encouraged to report any adverse reactions from the use of cosmetic products or any knowledge of improper cosmetic product promotion beyond its scope of use, to the National Pharmaceutical Control Bureau (NPCB) at MOH,” she concludes. – Sandra Low

    Tuesday, October 23, 2012

    Health Ministry hails cigarette price hike

    theSundaily

    PETALING JAYA (Oct 23, 2012): The Health Ministry has welcomed the decision by British American Tobacco (BAT) Malaysia to increase the prices of all its cigarette packs by 20 sen.
    Health Minister Datuk Seri Liow Tiong Lai reasoned that price increases are an effective deterrent to smoking and there has been a significant reduction in the number of smokers with each increase.
    "This has been proven by our minimum pricing of RM 7. We are able to contain cigarettes as a luxury item. We don't want youths to pick up smoking," he said at a press conference at the ASLI Healthcare Forum 2012 at Sunway Medical Centre here yesterday.
    Liow said the ministry is working with the customs and the Finance Ministry to prevent illegal cigarette sales and ensure the implementation of the minimum price.
    He said measures such as graphic images on legally-sold cigarettes will make enforcement of cigarette sales easier because smuggled cigarette packs lack such features.
    "The smoker can be charged with possessing or buying illegal or smuggled cigarettes," he warned.
    BAT Malaysia announced the price hike on Sunday, pointing to the customs' mandated increase in the ex-factory pricing of cigarettes of between 26% and 58% effective last Friday.
    Liow also said his ministry and the government's Performance Management and Delivery Unit (Pemandu) have converted a Business Opportunities Lab into a Healthcare Entry Point Project (EPP) for senior citizens under the health National Key Economic Area (NKEA).
    "We have converted the Senior Living business opportunities sector into an EPP under Senior Living. We will assist businesses in three specific areas – retirement villages, home or mobile care and nursing homes," he explained.
    He added that a special dialogue session on this new EPP will be held for investors and key players.
    "We have to capture this opportunity to further improve the health sector and welcome more foreign investment in Malaysia," said Liow.
    Pemandu healthcare director Dr Chua Hong Teck said the new Senior Living EPP can generate RM1.3 billion in revenue by 2020.
    "By 2020, 10% of our population would be 60 and above. By 2050, about 20% of Malaysians will be in this bracket," said Chua.

    Monday, October 22, 2012

    Using stem cells to regenerate cartilage

    The Star


    A team of Malaysian doctors achieved success and gained international attention by being innovative, passionate – and a little bit crazy.
    ON a quiet weekend in 2011, hand surgeon Dr Ranjit Singh Gill flexed his fingers as he watched a limousine and police outriders pull up to the front entrance of the Kuala Lumpur Sports Medicine Centre (KLSMC).
    A middle-aged man emerged from the car flanked by bodyguards. Dr Ranjit Singh greeted his patient. The whole group crowded into an elevator which took them to the fifth floor where a magnetic resonance imaging (MRI) machine awaited. The bodyguards stood sentry outside.
    “My arm has been bothering me,” the patient told Dr Ranjit Singh. After he gently flexed his patient’s arm and studied the MRI scans, he suggested that the patient undergo keyhole surgery and five rounds of stem cell injections.
    These stem cells would repair the injured area and regenerate the cartilage tissue. The treatment was so simple, it was almost too good to be true.
    In fact, global experts in the field of orthopaedics are divided over the use of adult stem cells to repair cartilage.
    “Cartilage basically does not heal,” Dr Hubert Kim, director of the Cartilage Repair and Regeneration Center at the University of California, San Francisco (UCSF) Medical Center, is quoted as saying in an interview on the centre’s website.
    Dr Ranjit Singh’s treatment, developed in Malaysia, flew in the face of medical textbooks. It took guts to suggest the road less travelled.
    “Doctors should always take the route that’s safest for the patient. But sometimes, the textbook solution is not necessarily the safest way of doing things,” Dr Ranjit Singh told me in a series of interviews, as he recounted treating this unique patient, who shall go unnamed because of doctor-patient confidentiality.
    “You need to continuously challenge yourself with difficult decisions. It’s a big responsibility.”
    That is leadership on the cutting-edge, metaphorically and medically speaking. Thanks to its doctors’ research on stem cell therapy, the KLSMC has emerged as a clinical and research powerhouse for orthopaedic work globally, achieving a pace of innovation unmatched by most private practices in the country.
    Stem cells being injected into a patient’s knee.Stem cells being injected into a patient’s knee.
    The doctors here have temerity, talent and a good track record to provide cutting-edge – sometimes experimental – treatments to rival the best in advanced nations.
    The KLSMC journey toward the cutting-edge began in 2005 when Dr Ranjit Singh’s colleague, orthopaedic surgeon and KLSMC founder Dr Saw Khay Yong, successfully regenerated cartilage in the knee joints of goats.
    Then, Dr Saw tried to regenerate normal cartilage in patients’ knees by injecting the patients’ own blood stem cells into their knees after drilling holes into the underlying bone. That worked too.
    Drawing on Dr Saw’s success with knees, Dr Ranjit Singh tested out the articular cartilage regeneration procedure on the limbs of three patients. Again, success. Cartilage could be regrown.
    The early studies, published in international scientific journals, drew interest from orthopaedic specialists and university lecturers from the United States and Britain, who flew to Kuala Lumpur to learn the latest techniques from KLSMC.
    “Their technology will change orthopaedic surgery forever,” Dr Adam Anz, a Florida orthopaedic surgeon, said in an interview.
    Exciting as that was, Dr Ranjit Singh was now recommending this relatively new procedure – tested on a bunch of goats and a few people – to one of the most famous people in Malaysia.
    “This procedure isn’t in the medical textbooks,” Dr Ranjit Singh told his patient. “Will you consider it?”
    Dr Ranjit Singh going over a case with a patient.Dr Ranjit Singh going over a case with a patient.
    “I’ll think about it,” the patient said.
    Dr Ranjit Singh shook his head as he watched his patient hop into the limo and leave the hospital accompanied by the wail of police sirens.
    Was he brilliant? Or crazy? Probably both, he concluded.
    It is the norm for doctors to leave the public health system to join private practice. It is unusual for a half-dozen orthopaedic specialists, headed by Dr Saw, to leave their private practice to start their own hospital in Bukit Damansara.
    It’s extremely rare for such doctors to embark on stem cell research – even while they were designing the hospital building and paying off mortgages and praying for patients to show up. And it’s probably crazy to think of even setting up a stem cell lab in a country where research infrastructure is relatively sparse.
    “Is there a better way of doing things in hospitals?” Dr Saw mused aloud during an interview at Nerofico, an Italian restaurant on the ground floor of KLSMC, which serves gourmet food to its patients. “We dreamed of seeing and scanning the patient the same day, and then doing surgery the next day.”
    “We were passionate and obsessive about wanting to do things properly. But logically, the risk was still too high to set up a centre so big,” Dr Ranjit Singh added, as he gestured broadly toward the nine floors of the hospital, which includes a pharmacy, a laboratory, operating theatres, a gorgeous high-ceilinged physiotherapy centre on the eighth floor and a rooftop hydrotherapy pool.
    “So we needed the final magic ingredient: you have to be a little bit crazy.”
    Their craziness has paid off. Thanks to their original research conducted with Universiti Putra Malaysia in 2005, Dr Saw and his colleagues began providing stem cell therapy for sports-related and other common joint injuries.
    Soon they found themselves treating national athletes, weightlifters and international patients.
    In May this year, world No 1 badminton player Datuk Lee Chong Wei injured his right ankle. Most Malaysians wrote off his chances of competing at the London Olympics. Lee went to KLSMC for stem cell injections into a torn ligament. He recovered quickly.
    A few months later, Dr Saw found himself joining millions of Malaysians cheering on Lee in the breathtaking Olympic final against Lin Dan. “I was watching his ankle all the time and hoping he wouldn’t twist it again.”
    Dr Saw’s pioneering work in regenerating knee cartilage has won praise from the editors of the peer-reviewed Journal Of Arthroscopic And Related Surgery. In two separate editorials, editor-in-chief Professor Gary Poehling urged readers to study the research published by Dr Saw in Malaysia and his co-authors in North Carolina and Alaska.
    Prof Poehling described the diagrams as “amazing” and “priceless” and concluded that “stem cells have vast potential”. Dr Saw continues to publish papers that show evidence that articular cartilage in the knee joint can be regenerated.
    Dr Saw Khay Yong: ‘We were passionate and obsessive about wanting to do things properly,’ he says of the KLSMC setup.Dr Saw Khay Yong: ‘We were passionate and obsessive about wanting to do things properly,’ he says of the KLSMC setup.
    The KLSMC doctors’ research has now broadened stem cell treatment into cartilage, soft tissue, nerves and tendons – building on ground-breaking work carried out by specialists in multiple fields throughout the world.
    “Right now this is the best possible treatment ever,” said Dr Anz, who has flown to Malaysia several times to learn new techniques and collaborate with Dr Saw.
    “We want to give our patients the best treatment possible. Once they see it involves stem cells – and they see how it’s so easy to harvest, easy to process, easy to store and easy to inject into (a) patient – that’s going to change the world.”
    Currently, Dr Saw and his colleagues are planning a worldwide multicentre trial. The goal is to prove to the global medical fraternity that this form of stem cell treatment works.
    “As we will be the principal investigator, a worldwide randomised control trial will showcase biotechnology in Malaysia,” Dr Saw said. “You’ll change the way cartilage injuries are treated. And you’ll rewrite the textbooks.”
    Dr Ranjit Singh wasn’t out to rewrite textbooks when he began treating his patient with the arm problem. All he wanted to do was provide the best care possible. So he sent an e-mail to two famous orthopaedic surgeons asking a second opinion on whether or not he should inject stem cells into his famous patient.
    “Are you crazy?” a doctor from France replied. However, Dr Ranjit Singh’s mentor urged him to go for it. Faced with two opposite opinions, he knew what he had to do: he went for it.
    “It will take several weeks for the stem cells to recognise the injured area and regenerate the tissue, which will reattach back to the bone,” he explained to his patient.
    After the keyhole surgery, the patient returned to KLSMC five times for stem cell injections.
    Four months later, Dr Ranjit Singh met his patient and asked: “How’s the arm?”
    “Perfectly fine,” the patient replied.
    As the surgeon reflected on his unique patient – just one among many cases he has treated – perhaps the biggest leadership lesson he learned is to do what you love.
    “Doing what you love will drive you all the way – to be focused and persistent, to practise and practise, and finally to have that extra bit of craziness that pushes you forward.
    “If you love your job, you’ll do well in it. And if you do well in it, you’ll love your job,” he said.

    Thursday, October 18, 2012

    Malaysia drugs firms net RM34m sales

    BT


    he Malaysian pharmaceutical industry generated sales worth RM34.1 million at the Convention on Pharmaceutical Industry (CPhI) Worldwide 2012 in Madrid, Spain, from Oct 9 to Oct 11.

    The Malaysia External Trade Development Corporation (Matrade) said the event was a collaboration between Matrade and the Health Ministry to promote exports of Malaysian pharmaceutical products.

    CPhI Worldwide is the world's leading networking event for the pharmaceutical industry especially for sourcing contract manufacturing opportunities and collaborations in generic drugs.

    "Eleven Malaysian pharmaceutical companies were represented at the event, of which eight were under Matrade-led Malaysia’s national pavilion," Matrade said in a statement.

    A total of 174 business meetings took place between Malaysian companies and foreign buyers from various countries such as India, Sweden, Portugal, the United States, Mexico, Algeria, Ukraine, Iran, United Kingdom, Russia, Germany and Australia.

    Among the products foreign buyers wanted to source are ethical drugs, paediatric care, dermatological care, nutraceutical products, intravenous solutions, small volume injections, wound healing for diabetics, food supplements and natural colorant powders, it said.

    Matrade said the Malaysian participants were also approached by potential partners from India, Mexico, Algeria, Iran and Czech Republic for possible collaborations in contract manufacturing.

    With the encouraging result from our inaugural participation in this event, Matrade, the Health Ministry and the industry will continue to work together to ensure our continued presence at this leading event for the pharmaceutical industry, it said.

    The forthcoming event by Matrade to promote pharmaceutical products will see Malaysian companies' participation in the Arab Health 2013, which will be held in Dubai from Jan 28 to 31, 2013, it added. -- BERNAMA

    New UN initiative uses mobile technology to help fight non-communicable diseases

    UN


    17 October 2012 – Two United Nations agencies today launched a new initiative called ‘m-Health’ to use mobile technology, particularly text messaging and applications, to help tackle non-communicable illnesses such as diabetes, cancer, cardiovascular diseases and chronic respiratory diseases.
    “Technological innovations are changing the landscape of disease prevention and control. The widespread availability of mobile technology, including in many of the least developed countries, is an exceptional opportunity to expand the use of e-health,” said the Secretary-General of the International Telecommunication Union (ITU), Hamadoun I. Touré.
    Through the initiative, the ITU and the World Health Organization (WHO) will provide evidence-based and operational guidance to encourage partners worldwide, especially governments, to implement m-Health interventions to address prevention and treatment of non-communicable diseases (NCDs) and their common risk factors – tobacco use, unhealthy diet, physical inactivity and the harmful use of alcohol.
    Non-communicable diseases are some of the leading causes of death and disease in both developed countries and emerging economies alike, according to a news release issued by the agencies. They dominate health care needs and expenditures in most developed as well as most low- and middle-income countries.
    Of the 57 million deaths globally, NCDs contribute to an estimated 36 million deaths every year, including 14 million people dying between the ages of 30 and 70. Using mobile telephone technology, m-Health practices can help save lives, reduce illness and disability, and reduce healthcare costs significantly.
    “By joining forces, ITU and WHO will fight against debilitating non-communicable diseases that can be controlled through the intervention of m-Health solutions and services that are at once cost effective, scalable and sustainable,” said Mr. Touré. “In doing so, we will help end a scourge that hinders economic growth and development around the world.”
    The initiative will build on current projects, existing health systems and platforms, and will involve partnerships between governments, non-governmental organizations (NGOs) and the private sector.
    “WHO is already using mobile devices to carry out surveillance of non-communicable diseases and their risk factors,” said WHO’s Assistant Director-General for Non-communicable Diseases and Mental Health, Oleg Chestnov.
    “For example, the Global Adult Tobacco Surveillance system has used mobile phones to capture data on tobacco use in 17 countries – covering over half of the world’s population. This experience of running population-scale mobile projects will be vital to the initiative,” he stated.
    WHO and ITU member countries are also testing mobile solutions for NCDs – ranging from providing assistance to help people quit tobacco, helping people increase their activity levels, eating more healthily and helping patients with non-communicable diseases better manage their conditions. All of these experiences will feed into the new initiative.
    The new initiative will initially run for a four-year period and focus on prevention, treatment and enforcement to control non-communicable diseases.
    It is currently being discussed in Dubai at ITU Telecom World 2012, where leaders and pioneers in the corporate, research and academic sectors are meeting with high-ranking policy-makers and regulators, with the aim of sharing ideas on the future of global telecommunications.

    Wednesday, October 17, 2012

    Global spread of resistant microorganisms a nightmare

     The Star Online


    PUTRAJAYA: A powerful antibiotic to treat serious bacterial infections is no longer effective in six out of 10 patients as a result of years of widespread abuse of antibiotics in the country.
    Citing an example, Health Minister Datuk Seri Liow Tiong Lai said the antibiotic carbapenem used to fight Acinetobacter baumanii, a bacteria that causes dangerous secondary infections in hospitals, was no longer effective in 57.4% of cases last year, a drastic increase from 35% in 2005.
    “Likewise, the microorganism Streptococcus pneumoniae that causes pneumonia, among many others, showed resistance in 30.9% of the time in 2010, up from 21.9% in 2003,” he added when launching the National Campaign on the Containment of Antimicrobial Resistance or AMR here yesterday.
    Carbapenems are among the antibiotics of last resort for many bacterial infections. There are no new antibiotics in the forseeable future to combat this resistance, and the worldwide spread of the resistant gene is now considered a nightmare for the medical community.
    The national campaign to curb the misuse of antibiotics will involve both the private and public sectors although it is far easier to control the practice of government doctors, said Datuk Dr Azmi Shapie, director of the Medical Development Division in the Health Ministry.
    Speaking at a media workshop after the launch, he said: “AMR is an extremely serious global problem because it means that many infections are no longer easily treated, leading to prolonged suffering and greater risk of death for patients.
    “In addition, the cost of healthcare increases because more expensive drugs are needed, in addition to longer treatment durations.”
    In 90% of cases, antibiotics were of no use against ailments like coughs, colds or sore throats as these were mainly viral, rather than bacterial, said Datuk Dr Christopher Lee, head of the infectious disease unit at the Sungai Buloh Hospital in Selangor,
    He also said doctors should not hastily prescribe antibiotics while patients should not be quick to demand for them.